Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03307330 · ClinicalTrials.gov registry record
A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea
A clinical trial of Obstructive Sleep Apnea of Adult, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT03307330: Recruiting study of Obstructive Sleep Apnea of Adult, sponsored by Mayo Clinic.
NCT03307330 is a study of Obstructive Sleep Apnea of Adult that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 120 participants, below the 510-participant average among 8 other Obstructive Sleep Apnea of Adult trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03307330, a study of Obstructive Sleep Apnea of Adult, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Studies show that sleep apnea increases the risk of cardiovascular disease and is associated with obesity. However, it is unclear how sleep apnea affects fat tissue. Studies have shown that fat tissue is likely involved in developing cardiovascular disease. The purpose of this study is to see how sleep apnea changes fat tissue.
Primary Outcome
Positivity for both (p16\^IND4A and γH2AX) serves as a marker of cellular damage. A fat biopsy from the abdomen and thigh will be performed to obtain up to 1 gm of adipose tissue from each site. These fat samples will be batched for analysis.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2029-12 |
What NCT03307330 shows while recruiting
NCT03307330 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 510-participant average among 8 other Obstructive Sleep Apnea of Adult trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Obstructive Sleep Apnea of Adult appearing as the primary indexed condition, and to 0 interventions.
NCT03307330 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03307330 about?
NCT03307330 is a clinical study titled "A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea". Studies show that sleep apnea increases the risk of cardiovascular disease and is associated with obesity. However, it is unclear how sleep apnea affects fat tissue. Studies have shown that fat tissue is likely involved in developing cardiovascular disease. The purpose of this study is to see how sl...
What is the current status of trial NCT03307330?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2018-01-08. Estimated completion is 2029-12.
What conditions does trial NCT03307330 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea of Adult.
Who is sponsoring clinical trial NCT03307330?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03307330 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea of Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03307330's enrollment target sits among peer trials
120 6th of 8 higher than 3 of 8 other Obstructive Sleep Apnea of Adult trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea of Adult trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea
RECRUITING · NA
-
Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy
RECRUITING · NA
-
Impact GLP-1 Agonists Following Bariatric
RECRUITING · Phase 4
-
Vascular Endothelial Dysfunction in Sleep Apnea
RECRUITING · Phase 1
-
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
RECRUITING · NA
-
Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI